End-to-end peptide development services cover the entire lifecycle of a peptide drug, from early discovery through to commercial manufacturing. This integrated approach reduces technology transfer risks, accelerates timelines, and provides a single point of accountability for peptide development programs.
Discovery services include custom peptide synthesis for target validation, SAR studies, and lead optimization. High-throughput synthesis capabilities enable rapid generation of libraries for screening. Medicinal chemistry expertise guides optimization of potency, selectivity, and pharmacokinetic properties. Early engagement with development teams can identify potential scale-up issues before they become problems.
Development services include process development, analytical method development, and formulation development. Process development identifies the most efficient synthesis route and optimizes purification conditions. Analytical method development establishes methods for quality control and stability testing. Formulation development optimizes the drug product formulation for stability and administration.
Manufacturing services include GMP production for clinical trials and commercial supply. The GMP facility is designed for both clinical and commercial supply, with flexible batch sizes and robust documentation. Regulatory support includes comprehensive documentation for IND and NDA filings, including synthesis, characterization, and stability data.
This integrated approach offers significant advantages over using multiple providers for different stages of development. By maintaining continuity throughout the development process, we minimize the risk of changes in product quality or performance during technology transfer. At PeptideHub, our end-to-end capabilities ensure seamless progression from discovery through to commercialization.